Feasibility and safety of ALVAC-HIV vCP1521 vaccine in HIV-exposed infants in Uganda: results from the first HIV vaccine trial in infants in Africa.
about
Hepatitis B vaccination for reducing morbidity and mortality in persons with HIV infectionContrasting Adult and Infant Immune Responses to HIV Infection and VaccinationThe evolution of poxvirus vaccinesNovel directions in HIV-1 vaccines revealed from clinical trialsNonreplicating vectors in HIV vaccines.The influence of delivery vectors on HIV vaccine efficacyImmunogenicity of ALVAC-HIV vCP1521 in infants of HIV-1-infected women in Uganda (HPTN 027): the first pediatric HIV vaccine trial in Africa.A phase I randomized clinical trial of candidate human immunodeficiency virus type 1 vaccine MVA.HIVA administered to Gambian infantsPedVacc 002: a phase I/II randomized clinical trial of MVA.HIVA vaccine administered to infants born to human immunodeficiency virus type 1-positive mothers in Nairobi.Prevention of mother-to-child transmission of HIV type 1: the role of neonatal and infant prophylaxis.Infant HIV-1 vaccines: supplementing strategies to reduce maternal-child transmission
P2860
Q24193121-A9023F58-D3B4-4DB6-AF4D-236A603FD74BQ26776518-B63868CB-BC18-4B6E-8144-124171F997BDQ26995905-1ED0941B-476F-4D2D-8DEE-44ADB2E42BEEQ33645528-E107FA8F-4081-4D79-951D-2AB1433321F8Q33693891-446A6D92-C31F-4253-90B0-20B168302DAFQ34077543-97A56644-DA3E-4F2C-9D1E-46B41F0075D7Q34229329-B7E23F4B-FCC3-4F99-B36C-C694BCCC7A29Q35036289-C40BA438-EF04-48A8-925C-6EBDB4FEC6ECQ35554825-169229DE-9467-46EB-AB1B-762647460AA9Q35751105-D59D4ED3-848F-489F-B96B-F72798635FF0Q35903454-3A6FECB4-9B07-4BC5-91A0-69D38E6676E2
P2860
Feasibility and safety of ALVAC-HIV vCP1521 vaccine in HIV-exposed infants in Uganda: results from the first HIV vaccine trial in infants in Africa.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Feasibility and safety of ALVA ...... ne trial in infants in Africa.
@ast
Feasibility and safety of ALVA ...... ne trial in infants in Africa.
@en
type
label
Feasibility and safety of ALVA ...... ne trial in infants in Africa.
@ast
Feasibility and safety of ALVA ...... ne trial in infants in Africa.
@en
prefLabel
Feasibility and safety of ALVA ...... ne trial in infants in Africa.
@ast
Feasibility and safety of ALVA ...... ne trial in infants in Africa.
@en
P2093
P2860
P1476
Feasibility and safety of ALVA ...... ine trial in infants in Africa
@en
P2093
Brenda Asiimwe-Kateera
Kenneth Kintu
Laura Guay
Lynda Emel
Lynn Baglyos
Mary Glenn Fowler
Paul Richardson
Philip Andrew
Philippa Musoke
P2860
P356
10.1097/QAI.0B013E31827F1C2D
P407
P577
2013-05-01T00:00:00Z